HEStaff exchange2022–2026

VOLATEVS · Analysis of the volatile organic compounds emitted by extracellular vesicles for disease diagnosis

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2022-11-01 → 2026-10-31
EU contribution
€1,025,800
Participants
9
Scheme
HORIZON-TMA-MSCA-SE

Lines connect the coordinator with its partners.

Results in brief

Analysis of the volatile organic compounds emitted by extracellular vesicles for disease diagnosis

This project aims to investigate the potential of analysing the volatile organic compounds emitted by extracellular vesicles as an innovative approach for disease diagnostic. The extracellular vesicles are particles naturally released from cells, which can be found in many biological samples. They have the capacity to transfer information to other cells and influence recipient cell function. In this project, extracellular vesicles will be isolated from different biological samples, such as cancer cells, serum and urine. The results obtained in this project will ultimately allow assessing if the volatile organic compounds emitted by extracellular vesicles can provide additional information for disease diagnosis complementing the analysis of the biological samples from which they are extracted.

Data: CORDIS, © European Union

Project objective

This project aims at investigating the potential of analysing the volatile organic compounds emitted by extracellular vesicles as an innovative approach for disease diagnostic. Extracellular vesicles will be isolated from different biological samples, such as cancer cells, serum, urine and seminal bull sperm. The volatile organic compounds emitted by the extracellular vesicles will be analysed employing several techniques, which will include gas chromatography coupled to mass spectrometry, vibrational spectroscopy and electronic nose systems. The results obtained in this project will ultimately allow assessing if the volatile organic compounds emitted by extracellular vesicles can provide additional information for disease diagnosis complementing the analysis of the biological samples from which they are extracted.

Original text from CORDIS.

Participants

  • EESTI MAAULIKOOL · TartuCoordinatorEstonia
  • INSTITUTO DE INVESTIGACIONES CIENTIFICAS Y SERVICIOS DE ALTA TECNOLOGIA ASOCIACION SIN FINES DE LUCRO · Panama ClaytonPanama
  • INSTITUTUL DE CHIMIE MACROMOLECULARA PETRU PONI · IasiRomania
  • LUNDS UNIVERSITET · LundSweden
  • MGM STAR CONSTRUCT SRL · BucharestRomania
  • MONASH UNIVERSITY MALAYSIA SDN BHD · USJMalaysia
  • UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA · RomaItaly
  • UPPSALA UNIVERSITET · UppsalaSweden
  • Universiti Malaysia Sarawak · Kota SamarahanMalaysia

Links

Data: CORDIS, © European Union